AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
MANTLE-CELL LYMPHOMAS HAVE MORE WIDESPREAD DISEASE AND A SLOWER RESPONSE TO CHEMOTHERAPY COMPARED WITH FOLLICLE-CENTER LYMPHOMAS - RESULTS OF A PROSPECTIVE COMPARATIVE-ANALYSIS OF THE GERMAN LOW-GRADE LYMPHOMASTUDY-GROUP
Authors: HIDDEMANN W UNTERHALT M HERMANN R WOLTJEN HH KREUSER ED TRUMPER L REUSSBORST M TERHARDTKASTEN E BUSCH M NEUBAUER A KAISER U HANRATH RD MIDDEKE H HELM G FREUND M STEIN H TIEMANN M PARWARESCH R
Citation: W. Hiddemann et al., MANTLE-CELL LYMPHOMAS HAVE MORE WIDESPREAD DISEASE AND A SLOWER RESPONSE TO CHEMOTHERAPY COMPARED WITH FOLLICLE-CENTER LYMPHOMAS - RESULTS OF A PROSPECTIVE COMPARATIVE-ANALYSIS OF THE GERMAN LOW-GRADE LYMPHOMASTUDY-GROUP, Journal of clinical oncology, 16(5), 1998, pp. 1922-1930
DE-NOVO EXPRESSION OF THE ALPHA-5-BETA-1-FIBRONECTIN RECEPTOR IN HT29COLON-CANCER CELLS REDUCES ACTIVITY OF C-SRC, INCREASE OF C-SRC ACTIVITY BY ATTACHMENT ON FIBRONECTIN
Authors: SCHMIDT R STREIT M KAISER R HERZBERG F SCHIRNER M SCHRAMM K KAUFMANN C HENNEKEN M SCHAFERKORTING M THIEL E KREUSER ED
Citation: R. Schmidt et al., DE-NOVO EXPRESSION OF THE ALPHA-5-BETA-1-FIBRONECTIN RECEPTOR IN HT29COLON-CANCER CELLS REDUCES ACTIVITY OF C-SRC, INCREASE OF C-SRC ACTIVITY BY ATTACHMENT ON FIBRONECTIN, International journal of cancer, 76(1), 1998, pp. 91-98
PROTHYMOSIN ALPHA-1 EFFECTS ON IL-2-INDUCED EXPRESSION OF LFA-1 ON LYMPHOCYTES AND THEIR ADHESION TO HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS
Authors: GRUNBERG E ECKERT K MAURER HR IMMENSCHUH P KREUSER ED
Citation: E. Grunberg et al., PROTHYMOSIN ALPHA-1 EFFECTS ON IL-2-INDUCED EXPRESSION OF LFA-1 ON LYMPHOCYTES AND THEIR ADHESION TO HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS, Journal of interferon & cytokine research, 17(3), 1997, pp. 159-165
A PHASE-II TRIAL OF TRIMETREXATE (TMTX), 5-FLUOROURACIL (5-FU) AND FOLINIC ACID (FA) IN UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
Authors: KREUSER ED SZELENYI H HOHENBERGER P LOCHS H HABBOUBI N OSTER W THIEL E BERDEL WE
Citation: Ed. Kreuser et al., A PHASE-II TRIAL OF TRIMETREXATE (TMTX), 5-FLUOROURACIL (5-FU) AND FOLINIC ACID (FA) IN UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 33, 1997, pp. 755-755
QUALITY-OF-LIFE (QL) IS A PROGNOSTIC FACTOR (PF) FOR SURVIVAL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC)
Authors: HILGENFELD RU MANSMANN U GUGGENMOOSHOLZMANN I THIEL E KREUSER ED
Citation: Ru. Hilgenfeld et al., QUALITY-OF-LIFE (QL) IS A PROGNOSTIC FACTOR (PF) FOR SURVIVAL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC), European journal of cancer, 33, 1997, pp. 760-760
INTERIM-REPORT ON TOXICITY AND COMPLIANCE OF THE FOGT-1 AND FOGT-2 TRIALS FOR ADJUVANT POSTOPERATIVE THERAPY IN COLON-CANCER AND RECTAL-CANCER
Authors: LINK KH STAIB L BERNHART H KREUSER ED SUHR P ROTTINGER E BEGER HG
Citation: Kh. Link et al., INTERIM-REPORT ON TOXICITY AND COMPLIANCE OF THE FOGT-1 AND FOGT-2 TRIALS FOR ADJUVANT POSTOPERATIVE THERAPY IN COLON-CANCER AND RECTAL-CANCER, European journal of cancer, 33, 1997, pp. 1102-1102
5-DAY CONTINUOUS-INFUSION OF 5-FLUOROURACIL AND PULSED FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA - AN EFFECTIVE 2ND-LINE REGIMEN
Authors: STREIT M JAEHDE U STREMETZNE S RIDWELSKI K KERZ H STROHBACH F HOHENBERGER P ZWIEBEL FM HEBART H BOTHIG R KAIRIES M ZILLIG D SCHUCHMANN S WARNECKE S THIEL E KREUSER ED
Citation: M. Streit et al., 5-DAY CONTINUOUS-INFUSION OF 5-FLUOROURACIL AND PULSED FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA - AN EFFECTIVE 2ND-LINE REGIMEN, Annals of oncology, 8(11), 1997, pp. 1163-1165
ACCEPTANCE AND TOXICITY OF POSTOPERATIVE ADJUVANT THERAPY IN COLON AND RECTAL CANCERS - INTERIM REPORT ON THE TRIALS FOGT1 AND FOGT2 OF THEGERMAN SCHUNGSGRUPPE-ONKOLOGIE-GASTROINTESTINALER-TUMOREN (FOGT)
Authors: LINK KH STAIB L BERNHART H KREUSER ED SUHR P ROTTINGER E BEGER HG KRAUTZBERGER W BEWERSDORF H KAHLE M SCHWANGHART F KARN B SCHMELZ M RUNKEL N BAER U SEMLER P LUDTKEHANDJERY A RUPPEL FJ AUGENSTEIN H ENGEL R THOLL U MEISSNER D KLIEBISCH S PAUL U PLATZ M SCHMIDT W KUHLGATZ J HENZLER M SCHRAMM H TEICHER R STELZER E BAUMANN W KURRLE E BUCHELT L LIERSCH T MAO R HECKER U WACKE W GOTH B BRULLKE N VOGT J MEUSEL P STEINHAUER EU KNUFERMANN H LANDES T VEHLINGKAISER U SCHENKER U KOGEL H JOST KA MENTZEL M KUJATH P ZERBIAN KU LORENZ S AHLEMANN LM MOKROS W KETTNER E RIDWELSKI K ROSCHER R LANGE J RATH W EBERT KH FISCHER M SCHERBER A BECK J FUHLROTT M LENZ P GABRIEL P BARTEL F WEISER HF SCHUTZE F MULLER C ALBRECHT J BOTHIG R FRANK R LEIBL B PATSAS JR WEBER W RENDENBACH B SCHMIDT R LUTZ M SCHNEIDERKAPPUS W SCHNEIDER M SIMANK P DISEBASTIANO P
Citation: Kh. Link et al., ACCEPTANCE AND TOXICITY OF POSTOPERATIVE ADJUVANT THERAPY IN COLON AND RECTAL CANCERS - INTERIM REPORT ON THE TRIALS FOGT1 AND FOGT2 OF THEGERMAN SCHUNGSGRUPPE-ONKOLOGIE-GASTROINTESTINALER-TUMOREN (FOGT), Onkologie, 20(3), 1997, pp. 235-238
PROTHYMOSIN ALPHA-1 EFFECTS, IN-VITRO, ON THE ANTITUMOR-ACTIVITY AND CYTOKINE PRODUCTION OF BLOOD MONOCYTES FROM COLORECTAL TUMOR PATIENTS
Authors: GARBIN F ECKERT K IMMENSCHUH P KREUSER ED MAURER HR
Citation: F. Garbin et al., PROTHYMOSIN ALPHA-1 EFFECTS, IN-VITRO, ON THE ANTITUMOR-ACTIVITY AND CYTOKINE PRODUCTION OF BLOOD MONOCYTES FROM COLORECTAL TUMOR PATIENTS, International journal of immunopharmacology, 19(6), 1997, pp. 323-332
INTERLEUKIN-2-ACTIVATED KILLER-CELL ACTIVITY IN COLORECTAL TUMOR PATIENTS - EVALUATION OF IN-VITRO EFFECTS BY PROTHYMOSIN ALPHA-1
Authors: ECKERT K GRUNBERG E IMMENSCHUH P GARBIN F KREUSER ED MAURER HR
Citation: K. Eckert et al., INTERLEUKIN-2-ACTIVATED KILLER-CELL ACTIVITY IN COLORECTAL TUMOR PATIENTS - EVALUATION OF IN-VITRO EFFECTS BY PROTHYMOSIN ALPHA-1, Journal of cancer research and clinical oncology, 123(8), 1997, pp. 420-428
DOSE INTENSITY PHASE I II TRIAL WITH CARBOPLATIN, IFOSFAMIDE, ETOPOSIDE AND VINCRISTINE COMBINED WITH FILGRASTIM IN PATIENTS WITH SMALL-CELL LUNG-CANCER/
Authors: HANAUSKE AR KORFEL A PERKER M HEINRICH B SCHWAB G GRAF M DEPENBROCK H HOFFKEN G KREUSER ED THIEL E ZWINGERS T BERDEL WE
Citation: Ar. Hanauske et al., DOSE INTENSITY PHASE I II TRIAL WITH CARBOPLATIN, IFOSFAMIDE, ETOPOSIDE AND VINCRISTINE COMBINED WITH FILGRASTIM IN PATIENTS WITH SMALL-CELL LUNG-CANCER/, Oncology, 54(5), 1997, pp. 363-370
IS THERE SUCH A THING AS MAGNESIUM-DEFICI ENCY ANEMIA
Authors: SZELENYI H KREUSER ED
Citation: H. Szelenyi et Ed. Kreuser, IS THERE SUCH A THING AS MAGNESIUM-DEFICI ENCY ANEMIA, Deutsche Medizinische Wochenschrift, 121(27), 1996, pp. 886-886
PHASE-II PILOT TRIAL OF PREOPERATIVE HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH MALIGNANT-TUMORS OF THE UPPER GASTROINTESTINAL-TRACT
Authors: BERDEL WE HELDMANN T GERMER C WIEDENMANN B ROSEWICZ S BOESELANDGRAF J KARAVIAS T KREUSER ED BUHR HJ THIEL E
Citation: We. Berdel et al., PHASE-II PILOT TRIAL OF PREOPERATIVE HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH MALIGNANT-TUMORS OF THE UPPER GASTROINTESTINAL-TRACT, International journal of oncology, 9(4), 1996, pp. 613-617
PHASE-II TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA), 5-FLUOROURACIL AND RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED GASTRIC-CARCINOMA
Authors: WADLER S GLEISSNER B HILGENFELD RU THIEL E HAYNES H KALEYA R ROZENBLIT A KREUSER ED
Citation: S. Wadler et al., PHASE-II TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA), 5-FLUOROURACIL AND RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED GASTRIC-CARCINOMA, European journal of cancer, 32A(7), 1996, pp. 1254-1256
ADHESION RECEPTORS IN MALIGNANT TRANSFORMATION AND DISSEMINATION OF GASTROINTESTINAL TUMORS
Authors: STREIT M SCHMIDT R HILGENFELD RU THIEL E KREUSER ED
Citation: M. Streit et al., ADHESION RECEPTORS IN MALIGNANT TRANSFORMATION AND DISSEMINATION OF GASTROINTESTINAL TUMORS, Journal of molecular medicine, 74(5), 1996, pp. 253-268
FATAL MUCOR PNEUMONIA AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE FORNON-HODGKINS-LYMPHOMA
Authors: SZELENYI H FOSS HD KREUSER ED KNAUF W THIEL E
Citation: H. Szelenyi et al., FATAL MUCOR PNEUMONIA AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE FORNON-HODGKINS-LYMPHOMA, Annals of hematology, 73(3), 1996, pp. 145-147
PREDNIMUSTINE, MITOXANTRONE (PMM) VS CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE (COP) FOR THE TREATMENT OF ADVANCED LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: UNTERHALT M HERRMANN R TIEMANN M PARWARESCH R STEIN H TRUMPER L NAHLER M REUSSBORST M TIRIER C NEUBAUER A FREUND M KREUSER ED DIETZFELBINGER H BODENSTEIN H ENGERT A STAUDER R EIMERMACHER H LANDYS K HIDDEMANN W
Citation: M. Unterhalt et al., PREDNIMUSTINE, MITOXANTRONE (PMM) VS CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE (COP) FOR THE TREATMENT OF ADVANCED LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia, 10(5), 1996, pp. 836-843
EXPRESSION AND FUNCTION OF RECEPTORS FOR EXTRACELLULAR-MATRIX PROTEINS IN HUMAN DUCTAL ADENOCARCINOMAS OF THE PANCREAS
Authors: LOHR M TRAUTMANN B GOTTLER M PETERS S ZAUNER I MAIER A KLOPPEL G LIEBE S KREUSER ED
Citation: M. Lohr et al., EXPRESSION AND FUNCTION OF RECEPTORS FOR EXTRACELLULAR-MATRIX PROTEINS IN HUMAN DUCTAL ADENOCARCINOMAS OF THE PANCREAS, Pancreas, 12(3), 1996, pp. 248-259
SUCCESSFUL EMERGENCY SPLENECTOMY DURING PREGNANCY IN A PATIENT WITH LIFE-THREATENING IDIOPATHIC THROMBOCYTOPENIA - CASE-REPORT
Authors: STIEMER B OPRI F SENGER D KREUSER ED BERDEL W HOPP H SANFT K BAUER K WEITZEL HK
Citation: B. Stiemer et al., SUCCESSFUL EMERGENCY SPLENECTOMY DURING PREGNANCY IN A PATIENT WITH LIFE-THREATENING IDIOPATHIC THROMBOCYTOPENIA - CASE-REPORT, Journal of perinatal medicine, 24(6), 1996, pp. 703-706
IL-4 AND TNF-ALPHA INDUCE CHANGES IN INTEGRIN EXPRESSION AND ADHESIVEPROPERTIES AND DECREASE THE LUNG-COLONIZING POTENTIAL OF HT-29 COLON-CARCINOMA CELLS
Authors: HERZBERG F SCHONING M SCHIRNER M TOPP M THIEL E KREUSER ED
Citation: F. Herzberg et al., IL-4 AND TNF-ALPHA INDUCE CHANGES IN INTEGRIN EXPRESSION AND ADHESIVEPROPERTIES AND DECREASE THE LUNG-COLONIZING POTENTIAL OF HT-29 COLON-CARCINOMA CELLS, Clinical & experimental metastasis, 14(2), 1996, pp. 165-175
DIFFERENT CD44 SPLICING PATTERNS DEFINE PROGNOSTIC SUBGROUPS IN MULTIPLE-MYELOMA
Authors: STAUDER R VANDRIEL M SCHWARZLER C THALER J LOKHORST HM KREUSER ED BLOEM AC GUNTHERT U EISTERER W
Citation: R. Stauder et al., DIFFERENT CD44 SPLICING PATTERNS DEFINE PROGNOSTIC SUBGROUPS IN MULTIPLE-MYELOMA, Blood, 88(8), 1996, pp. 3101-3108
DIFFERENTIAL-DIAGNOSIS OF ACUTE EOSINOPHILIC LEUKEMIA VERSUS HYPEREOSINOPHILIC SYNDROME FACILITATED BY THE DETECTION OF WILMS-TUMOR GENE-EXPRESSING MONONUCLEAR-CELLS
Authors: BARTELT S MENSSEN HD RENKL HJ RIEDER H NOTTER M KREUSER ED THIEL E
Citation: S. Bartelt et al., DIFFERENTIAL-DIAGNOSIS OF ACUTE EOSINOPHILIC LEUKEMIA VERSUS HYPEREOSINOPHILIC SYNDROME FACILITATED BY THE DETECTION OF WILMS-TUMOR GENE-EXPRESSING MONONUCLEAR-CELLS, Blood, 88(10), 1996, pp. 3331-3331
CD44 VARIANT ISOFORMS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - EVIDENCE FOR DIFFERENT SPLICING PATTERNS ACCORDING TO THE PHENOTYPE
Authors: KREUSER ED GUNTHERT U STREIT M SCHWARTZ S STAUDER R KOMISCHKE B HOELZER D GOKBUGET N REHDER H RIEDER H THIEL E
Citation: Ed. Kreuser et al., CD44 VARIANT ISOFORMS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - EVIDENCE FOR DIFFERENT SPLICING PATTERNS ACCORDING TO THE PHENOTYPE, Blood, 88(10), 1996, pp. 295-295
INCIDENCE AND SIGNIFICANCE OF TREATMENT-A SSOCIATED LATE COMPLICATIONS IN HODGKINS-DISEASE
Authors: STREIT M THIEL E KREUSER ED
Citation: M. Streit et al., INCIDENCE AND SIGNIFICANCE OF TREATMENT-A SSOCIATED LATE COMPLICATIONS IN HODGKINS-DISEASE, Deutsche Medizinische Wochenschrift, 120(31-32), 1995, pp. 1093-1099
PHASE-I TOLERABILITY STUDY OF 5-METHYLTETRAHYDROFOLATE IN COMBINATIONWITH A 4-HOUR INFUSION OF 5-FLUOROURACIL IN CANCER-PATIENTS
Authors: KORFEL A KREUSER ED HOEFFKEN G BAUMGART J SASS G THIEL E BERDEL WE
Citation: A. Korfel et al., PHASE-I TOLERABILITY STUDY OF 5-METHYLTETRAHYDROFOLATE IN COMBINATIONWITH A 4-HOUR INFUSION OF 5-FLUOROURACIL IN CANCER-PATIENTS, International journal of oncology, 7(1), 1995, pp. 65-68
Risultati: 1-25 | 26-38